Jakafi = Novartis
It appears that a huge competitor has become friend.
Why?
We know many of the short comings of Jakafi including safty and limited trial data for GVHD. This goes beyond GVHD
COVID 19
https://www.sciencedirect.com/science/article/pii/S0924857920301862
In my view we have a safe and reliable replacement for Jakafi. Novartis had to become friend or face economic ruin. A head to head trial forced the point home.
As though replacement of Jakafi is not large enough . This goes beyond Jakafi and consideration for same is still to come.
Entresto, Novartis CHFhttps://hotcopper.com.au/posts/47449136/single
The CAR-T treatments on the market—Novartis’
https://hotcopper.com.au/posts/47387975/single
We have the goods
Good luck all
- Forums
- ASX - By Stock
- MSB
- TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP, page-94
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.053B |
Open | High | Low | Value | Volume |
92.0¢ | 92.5¢ | 91.5¢ | $940.4K | 1.023M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 249621 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 123759 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 249454 | 0.915 |
23 | 189337 | 0.910 |
12 | 102928 | 0.905 |
46 | 439436 | 0.900 |
9 | 388314 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 123759 | 54 |
0.925 | 113848 | 16 |
0.930 | 79577 | 8 |
0.935 | 159648 | 8 |
0.940 | 18060 | 5 |
Last trade - 15.47pm 18/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |